Yahoo Web Search

Search results

1. • Playbux Rolls Out Two New Upgrades to Make its Ecosystem More Universal and Rewarding

     Digital Journal· 6 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

2. • Replimune (REPL) Gains on Positive Data From Melanoma Study

     Zacks· 2 days ago

     Free Report) announced positive top-line results from the primary analysis of the IGNYTE study on lead pipeline candidate RP1, in combination with Bristol Myers’ (BMY Quick QuoteBMY - Free Report ...

3. • MD Anderson Research Highlights for June 5, 2024 | Newswise

     Newswise· 4 days ago

     The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These

4. • MedTech Outlook 2024 for Latin America Released

     Digital Journal· 6 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

5. • A Bird’s Eye View of the Tumor Microenvironment

     The Scientist· 6 days ago

     The tumor microenvironment is a battleground where infiltrating immune cells either subdue or promote a cancer, all while cancer cells try to dampen the body’s defenses.1,2 Scientists have studied ...

6. • Onramp Hires Mark Connors as Managing Director, Head of Global Macro Strategy to Accelerate Bitcoin...

     Digital Journal· 6 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

7. • Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead...

     Benzinga· 6 days ago

     Strasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the ...

8. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 3 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) on behalf of long-term ...

9. • ONESTONE HOLDINGS Achieves Breakthrough in Green Hydrogen Production at Sea With Vertical Wind...

     Digital Journal· 6 days ago

     ...Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June...

10. • CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on...

      Benzinga· 3 days ago

      Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Checkpoint Therapeutics, Inc. CKPT on behalf of long-term stockholders ...